Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications

被引：32

作者：

Alvarez, C. A. ^{[1
,2
]}

Lingvay, I. ^{[3
]}

Vuylsteke, V. ^{[1
]}

Koffarnus, R. L. ^{[1
]}

McGuire, D. K. ^{[3
]}

机构：

[1] Texas Tech Univ, Hlth Sci Ctr, Dallas, TX 75235 USA

[2] Univ Texas Southwestern, Dallas, TX USA

[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 98卷 / 02期

基金：

美国国家卫生研究院;

关键词：

INTIMA-MEDIA THICKNESS; IMPAIRED GLUCOSE-TOLERANCE; INADEQUATE GLYCEMIC CONTROL; BLOOD-PRESSURE; HEART-FAILURE; ENDOTHELIAL FUNCTION; DOUBLE-BLIND; VASCULAR COMPLICATIONS; CLINICAL-IMPLICATIONS; NONDIABETIC PATIENTS;

D O I：

10.1002/cpt.143

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cardiovascular disease is the principal complication and the leading cause of death for patients with diabetes (DM). The efficacy of antihyperglycemic treatments on cardiovascular disease risk remains uncertain. Cardiovascular risk factors are affected by antihyperglycemic medications, as are many intermediate markers of cardiovascular disease. Here we summarize the evidence assessing the cardiovascular effects of antihyperglycemic medications with regard to risk factors, intermediate markers of disease, and clinical outcomes.

引用

页码：145 / 161

页数：17

共 75 条

[41] Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial [J].

Mazzone, Theodore ;

Meyer, Peter M. ;

Feinstein, Steven B. ;

Davidson, Michael H. ;

Kondos, George T. ;

D'Agostino, Ralph B., Sr. ;

Perez, Alfonso ;

Provost, Jean-Claude ;

Haffner, Steven M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (21) :2572-2581

[42] The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review [J].

McGill, Janet B. .

DIABETES THERAPY, 2014, 5 (01) :43-63

[43] New drugs for the treatment of diabetes mellitus - Part I: Thiazolidinediones and their evolving cardiovascular implications [J].

McGuire, Darren K. ;

Inzucchi, Silvio E. .

CIRCULATION, 2008, 117 (03) :440-449

[44] Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function [J].

McGuire, Darren K. ;

Abdullah, Shuaib M. ;

See, Raphael ;

Snell, Peter G. ;

McGavock, Jonathan ;

Szczepaniak, Lidia S. ;

Ayers, Colby R. ;

Drazner, Mark H. ;

Khera, Amit ;

de Lemos, James A. .

EUROPEAN HEART JOURNAL, 2010, 31 (18) :2262-2270

[45] Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension [J].

Mistry, Goutam C. ;

Maes, Andrea L. ;

Lasseter, Kenneth C. ;

Davies, Michael J. ;

Gottesdiener, Keith M. ;

Wagner, John A. ;

Herman, Gary A. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (05) :592-598

[46] Effects on Lipid Profile of Dipeptidyl Peptidase 4 Inhibitors, Pioglitazone, Acarbose, and Sulfonylureas: Meta-analysis of Placebo-Controlled Trials [J].

Monami, Matteo ;

Vitale, Valentina ;

Ambrosio, Maria Luisa ;

Bartoli, Nadia ;

Toffanello, Giulia ;

Ragghianti, Benedetta ;

Monami, Francesca ;

Marchionni, Niccolo ;

Mannucci, Edoardo .

ADVANCES IN THERAPY, 2012, 29 (09) :736-746

[47] Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials [J].

Monami, Matteo ;

Cremasco, Francesco ;

Lamanna, Caterina ;

Colombi, Claudia ;

Desideri, Carla Maria ;

Iacomelli, Iacopo ;

Marchionni, Niccolo ;

Mannucci, Edoardo .

EXPERIMENTAL DIABETES RESEARCH, 2011,

[48] Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [J].

Nathan, DM ;

Cleary, PA ;

Backlund, JYC ;

Genuth, SM ;

Lachin, JM ;

Orchard, TJ ;

Raskin, P ;

Zinman, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2643-2653

[49] Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin A randomized, 52-week, double-blind, active-controlled noninferiority trial [J].

Nauck, Michael A. ;

Del Prato, Stefano ;

Meier, Juris J. ;

Duran-Garcia, Santiago ;

Rohwedder, Katja ;

Elze, Martina ;

Parikh, Shamik J. .

DIABETES CARE, 2011, 34 (09) :2015-2022

[50] Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes -: The PERISCOPE randomized controlled trial [J].

Nissen, Steven E. ;

Nicholls, Stephen J. ;

Wolski, Kathy ;

Nesto, Richard ;

Kupfer, Stuart ;

Perez, Alfonso ;

Jure, Horacio ;

De Larochelliere, Robert ;

Staniloae, Cezar S. ;

Mavromatis, Kreton ;

Saw, Jacqueline ;

Hu, Bo ;

Lincoff, A. Michael ;

Tuzcu, E. Murat .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (13) :1561-1573

← 1 2 3 4 5 6 7 8 →